Circurna
Cambridge, United States· Est.
Develops RNA-targeting therapies for genetic diseases using circular RNA technology.
Private Company
Total funding raised: $50M
About
Develops RNA-targeting therapies for genetic diseases using circular RNA technology.
Genetics & GenomicsRNA Therapeutics
Funding History
1Total raised:$50M
Series A$50M